Product NDC: | 63739-154 |
Proprietary Name: | Lorazepam |
Non Proprietary Name: | Lorazepam |
Active Ingredient(s): | .5 mg/1 & nbsp; Lorazepam |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63739-154 |
Labeler Name: | McKesson Packaging Services Business Unit of McKesson Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA071193 |
Marketing Category: | ANDA |
Start Marketing Date: | 19990728 |
Package NDC: | 63739-154-01 |
Package Description: | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-154-01) > 25 TABLET in 1 BLISTER PACK |
NDC Code | 63739-154-01 |
Proprietary Name | Lorazepam |
Package Description | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-154-01) > 25 TABLET in 1 BLISTER PACK |
Product NDC | 63739-154 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lorazepam |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19990728 |
Marketing Category Name | ANDA |
Labeler Name | McKesson Packaging Services Business Unit of McKesson Corporation |
Substance Name | LORAZEPAM |
Strength Number | .5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |